NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 147 filers reported holding NEKTAR THERAPEUTICS in Q2 2014. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $823,000 | +32.3% | 59,876 | +65.0% | 0.00% | 0.0% |
| Q4 2015 | $622,000 | -2.2% | 36,290 | -28.6% | 0.00% | 0.0% |
| Q2 2015 | $636,000 | +3247.4% | 50,800 | +2904.1% | 0.00% | – |
| Q1 2015 | $19,000 | -99.0% | 1,691 | -98.6% | 0.00% | -100.0% |
| Q4 2014 | $1,829,000 | +135.7% | 119,091 | +85.2% | 0.00% | +200.0% |
| Q3 2014 | $776,000 | +42.4% | 64,300 | +26.6% | 0.00% | 0.0% |
| Q2 2014 | $545,000 | +51.0% | 50,800 | +47.1% | 0.00% | 0.0% |
| Q3 2013 | $361,000 | +27.6% | 34,532 | +40.8% | 0.00% | 0.0% |
| Q2 2013 | $283,000 | – | 24,526 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Strong Tower Advisory Services | 404,972 | $6,913,000 | 4.02% |
| GREAT POINT PARTNERS LLC | 504,691 | $9,064,000 | 2.11% |
| Camber Capital Management LP | 3,750,000 | $67,350,000 | 2.07% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,901,000 | 1.50% |
| Rhenman & Partners Asset Management AB | 950,000 | $17,062,000 | 1.20% |
| MAVERICK CAPITAL LTD | 5,838,426 | $104,858,000 | 1.06% |
| Birchview Capital, LP | 72,000 | $1,293,000 | 0.88% |
| Bellevue Group AG | 4,594,656 | $82,519,000 | 0.84% |
| CM Management, LLC | 50,000 | $898,000 | 0.67% |
| Duquesne Family Office | 1,000,000 | $17,960,000 | 0.58% |